Skip to main content
SpringerLink
Log in
Book cover

Recent Advances in Endometrial Cancer pp 297–307Cite as

Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMP)

  • Chapter
  • First Online:

  • 344 Accesses

Abstract

Smooth muscle Tumors of unknown malignant potential (STUMP) are a heterogenous group of uterine tumors which are clinically benign witha low malignant potential. They are extremely rare and have been reported in 0.01% of histological specimens. The clinical symptoms of STUMP mimic those of leiomyoma and so histopathological analysis forms the only reliable diagnostic method with imaging techniques and immunohistochemistry being supplementary. A multidisciplinary management is mandatory for early detection and to establish the treatment of choice in women with STUMP. Surgery forms the mainstay of treatment and the role of adjuvant therapy is less clear. The disease is known to recur/metastasize and patients with STUMP should be on long term surveillance.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Tavassoli FA, Devilee P. World Health Organization classification of Tumors: tumors of the breast and female genital organs. Lyon: International Agency for Research on Cancer Press; 2003. p. 236–9.

    Google Scholar 

  2. Kempson RL. Sarcomas and related neoplasms. In: Noris HJ, Hertig AT, Abel MR, editors. The uterus. Baltimore: Williams and Wilkins; 1973.

    Google Scholar 

  3. Picerno TM, Wasson MN, Gonzalez Rios AR, et al. Morcellation and the incidence of occult uterine malignancy: a dual institution review. Int J Gynecol Cancer. 2016;26(1):149–55.

    PubMed  Google Scholar 

  4. Bulun SE. Uterine fibroids. N Engl J Med. 2013;369:1344–55.

    CAS  PubMed  Google Scholar 

  5. Zivanoic O, Jacks LM, Lasonos A, Leitao MM, et al. A nomogram to predict post-resection 5-year overall survival for patients with leiomyosarcoma. Cancer. 2012;118:660–9.

    Google Scholar 

  6. Mehine M, Kaasinen E, Heinonen HR, Makinen N, Kampjarvi K, et al. Characterization of uterine leiomyomas by whole genome sequencing. PANS. 2015;113:1315–20.

    Google Scholar 

  7. Hodge JC, Pearce KE, Clayton AC, Taran FA, Stewart EA. Uterine cellular leiomyomata with chromosome 1p deletions represent a distinct entity. Am J Obstet Gynecol. 2014;210:572.

    PubMed  PubMed Central  Google Scholar 

  8. Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol. 1994 Jun;18(6):535–58.

    CAS  PubMed  Google Scholar 

  9. Tavassoli FA, Devilee P. World health Organization classification of tumors: tumors of the breast and female genital organs. Lyon: IARC Press.

    Google Scholar 

  10. Ip PP, Tse KY, Tam KF. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy. Adv Anat Pathol. 2010 Mar;17(2):91–112.

    PubMed  Google Scholar 

  11. Guntupalli SR, Ramirez PT, Anderson ML, Milam MR, Bodurka DC, Malpica A. Uterine smooth muscle tumor of uncertain malignant potential: a retrospective analysis. Gynecol Oncol. 2009;113(3):324–6.

    PubMed  Google Scholar 

  12. Deodhar KK, Goyal P, Rekhi B, et al. Uterine smooth muscle tumor of uncertain malignant potential and atypical leiomyoma: a morphological study of these grey zones with clinical correlation. Indian J Pathol Microbiol. 2011;54:706–11.

    PubMed  Google Scholar 

  13. Xiropotamou On, Tsili AC, Vrekousis TH et al. Uterine smooth muscle tumor of uncertain malignant potential: an entity difficult to diagnose. https://www.eurorad.org/case/12733.

  14. Ng JSY, Han A, Chew SH, Low J. A clinicopathologic study of uterine smooth muscle tumor of uncertain malignant potential. Ann Acad Med Singap. 2010;39:625–8.

    PubMed  Google Scholar 

  15. Yamashita Y, Torashima M, Takahashi M, et al. Hyperintense uterine leiomyoma at T2 weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications. Radiology. 1993;189:721–5.

    CAS  PubMed  Google Scholar 

  16. Tanaka YO, Nishida M, Tsunoda H, Okamoto Y, Yoshikawa H. Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings. J Magn Reson Imaging. 2004;20(6):998–1007.

    PubMed  Google Scholar 

  17. Sato K, Yuasa N, Fujita M, Fukishima Y. Clinical application of diffusion weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma. Am J Obstet Gynecol. 2014;210:358.

    Google Scholar 

  18. Bonneau C, Thomasin-Naggaua I, Dechow S, Cortez A, et al. value of ultrasonography and MRI imaging for the characterization of uterine mesenchymal tumors. Acta Oster Gynecol Scand. 2014;93(3):261–5.

    Google Scholar 

  19. de Vos S, Wilczynski SP, Fleischhacker M. Koeffler. p53 alterations in uterine leiomyosarcomas versus leiomyomas. Gynecol Oncol. 1994 Aug;54(2):205–8.

    CAS  PubMed  Google Scholar 

  20. Hong T, Shimada Y, Uchida S, Itami A, Li Z, Ding Y, Kaganoi J, Komoto I, Sakurai T, Imamura M. Expression of angiogenic factors and apoptotic factors in leiomyosarcoma and leiomyoma. Int J Mol Med. 2001 Aug;8(2):141–8.

    CAS  PubMed  Google Scholar 

  21. Jeffers MD, Farquharson MA, Richmond JA, McNicol AM. p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumors of the uterine corpus. J Pathol. 1995 Sep;177(1):65–70.

    CAS  PubMed  Google Scholar 

  22. Nordal RR, Kristensen GB, Stenwig AE, Trope CG, Nesland JM. Immunohistochemical analysis of p53 protein in uterine sarcomas. Gynecol Oncol. 1998;70:45–8.

    CAS  PubMed  Google Scholar 

  23. Wang M, Xu Y, Zhang T. Smooth muscle neoplasms of the uterus – a 51 cases study. Zhonghua Bing Li Xue Za Zhi. 1996;25:263–5.

    CAS  PubMed  Google Scholar 

  24. Chen L, Yang B. Immunohistochemical analysis of p16, p53 and ki67 expression in uterine smooth muscle tumors. Int J Gynecol Pathol. 2008;27:326–32.

    PubMed  Google Scholar 

  25. Atkins KA, Arronte N, DArus CJ, Rice LW. The use of p16 in enhancing the histologic classification of uterine smooth muscle tumors. Am J Surg Pathol. 2008;32:98–102.

    PubMed  Google Scholar 

  26. Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K, Mayerhofer K. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immune-histochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma. J Soc Gynecol Investig. 2001;11:187–91.

    Google Scholar 

  27. Won HS, Chun HG, Lee K. Retroperitoneal smooth muscle tumor of uncertain malignant potential after hysterectomy: a case report. J Med Case Rep. 2011;5:214.

    PubMed  PubMed Central  Google Scholar 

  28. Zhai YL, Kobayashi Y, Mori A, Orii A, Nikaido T, Konishi I, et al. Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas. Int J Gynecol Pathol. 1999;18:20–8.

    CAS  PubMed  Google Scholar 

  29. Mittal K, Demopoulos RI. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors. Hum Pathol. 2001;32:984–7.

    CAS  PubMed  Google Scholar 

  30. Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K, Mayerhofer K. Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors. Fertil Steril. 2004;81:1062–6.

    CAS  PubMed  Google Scholar 

  31. Gannon BR, Manduch M, Childs TJ. Differential immunoreactivity of p16in leimyosarcomas and leiomyoma variants. Int J Gynecol Pathol. 2008;27:68–73.

    PubMed  Google Scholar 

  32. Odunsi K, Pejovic T. Gynecological cancers multidisciplinary approach to diagnosis and treatment of uterine sarcoma. New York: Demos Publishing Company; 2013. p. 83–93.

    Google Scholar 

  33. Ayaz D, Diniz G, Kahraman DS, Sayhan S, Uncel M, et al. The evaluation of the caveolin-1 and At-rich interactive domain 1 alpha expressions in uterine smooth muscle tumors. Indian J Pathol Microbiol. 2016;59:301–4.

    PubMed  Google Scholar 

  34. Vahedpoor Z, Khamechian T, Zandi N. STUMP mistaken with ovarian tumor mistaken with ovarian tumor in a female with polio. J Obstet Gynecol Cancer Res. 2017;2:e9425.

    Google Scholar 

  35. Zhang Q, Ubago J, Li L. Molecular analysis of 6 different types of uterine smooth muscle tumors: emphasis in atypical leiomyoma. Cancer. 2014;120:3165–77.

    CAS  PubMed  Google Scholar 

  36. Ly A, Mills AM, McKenny JK. Atypical leiomyoma of the uterus: a clinicopathological study of 51 cases. Am J Surg Pathol. 2013;37:643–9.

    PubMed  Google Scholar 

  37. Canciani GN, Burbos N, Duncan TJ, Lonsdale R, Nieto JJ. Late presentation of metastatic smooth muscle neoplasm of the uterus with low malignant potential. J Gynecol Oncol. 2012;23:69–71.

    PubMed  PubMed Central  Google Scholar 

  38. Miller J, Shoni M, Siegert C. Benign metastasizing leiomyomas to the lungs: an institutional case series and a review of the recent literature. Ann Thorac Surg. 2016;101:253–8.

    PubMed  Google Scholar 

  39. Kotsupoulos IC, Barbetakis N, Asteriou C, et al. Uterine smooth muscle tumor of uncertain malignant potential: a rare cause of multiple pulmonary nodules. Indian J Med Paediat Oncol. 2012;33(3):176–8.

    Google Scholar 

  40. Kropp L, Siegal GP, Frampton GM, Rodriguez MG, McKee S, et al. Primary intraosseous smooth muscle tumor of uncertain malignant potential: original report and molecular characterization. Rare Tumors. 2016;4:2016–3613.

    Google Scholar 

  41. Shapiro A, Ferenczy A, Turcotte R, Bruchim I, Gotlieb WH. Uterine smooth muscle tumor of uncertain malignant potential metastasizing to the humerus as a high grade leiomyosarcoma. Gynecol Oncol. 2004;94:818–20.

    PubMed  Google Scholar 

  42. Philip PC, Tse KY, Tam KF. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern malignancy. Adv Anat Pathol. 2010;17(2):91–111.

    Google Scholar 

  43. Kalogiannidis I, Stavrakis T, Dagklis T, Petousis S, et al. A clinicopathological study of atypical leiomyomas: Benign variant leiomyoma or smooth muscle tumor of uncertain malignant potential. Oncol Lett. 2016;11:1425–8.

    PubMed  Google Scholar 

  44. Peeters N, Hulbosch S, Ballaux F, Baekelandt J. STUMP: analysis of diagnoses and therapies illustrated by two case reports. Eur J Gynecol Oncol. 2016;37:367–73.

    CAS  Google Scholar 

  45. Rommel B, Holzmann C, Bullerdiek J. Malignant mesenchymal tumors of the uterus-time to advocate a genetic classification. Expert Rev Anticancer Ther. 2016;111:1155–66.

    Google Scholar 

  46. Andrea DA, Gizzo S, Musaro A, Quaranta M, Noventa M, et al. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): pathology, follow-up and recurrence. Int J Clin Exp Pathol. 2014;7(11):8136–42.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics & Gynecology, Babu Jagjivan Ram Memorial Hospital, New Delhi, India

    Sumita Mehta & Ankita Mann

Authors
  1. Sumita Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ankita Mann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Obstetrics & Gynecology, Babu Jagjivan Ram Memorial Hospital, New Delhi, India

    Sumita Mehta

  2. Obstetrics and Gynecology, UCMS & GTB Hospital, Delhi, India

    Bindiya Gupta

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mehta, S., Mann, A. (2020). Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMP). In: Mehta, S., Gupta, B. (eds) Recent Advances in Endometrial Cancer. Springer, Singapore. https://doi.org/10.1007/978-981-15-5317-2_17

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-5317-2_17

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-5316-5

  • Online ISBN: 978-981-15-5317-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation